InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Chan Thomas (TC), 首席财务官. Director active across 1 company, notably GoodRx Holdings, Inc.. In total, 20 disclosures have been published. History available since 15 May 2026. The latest transaction was disclosed on 15 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Chan Thomas (TC)
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
638 股@ US$3.730.0002% mcap6.8% 占其流量Class A Common StockSEC:0001809519-26-000165:1
858 股@ US$3.730.0003% mcap9.1% 占其流量Class A Common StockSEC:0001809519-26-000165:3
1,342 股@ US$3.730.0004% mcap14.2% 占其流量Class A Common StockSEC:0001809519-26-000165:5
2,311 股@ US$3.730.0007% mcap24.5% 占其流量Class A Common StockSEC:0001809519-26-000165:7
1,252 股Class A Common StockSEC:0001809519-26-000165:0
1,686 股Class A Common StockSEC:0001809519-26-000165:2
2,636 股Class A Common StockSEC:0001809519-26-000165:4
4,541 股Class A Common StockSEC:0001809519-26-000165:6
2,947 股@ US$3.010.0009% mcap56.1% 占其流量Class A Common StockSEC:0001809519-26-000136:1
5,792 股Class A Common StockSEC:0001809519-26-000136:0
1,969 股Class A Common StockSEC:0001809519-26-000120:0
1,002 股Class A Common StockSEC:0001809519-26-000120:1
2,100 股Class A Common StockSEC:0001809519-26-000120:2
1,069 股Class A Common StockSEC:0001809519-26-000120:3
638 股@ US$2.490.0001% mcap22.5% 占其流量Class A Common StockSEC:0001809519-26-000115:1
1,342 股@ US$2.490.0003% mcap47.3% 占其流量Class A Common StockSEC:0001809519-26-000115:3
858 股@ US$2.490.0002% mcap30.2% 占其流量Class A Common StockSEC:0001809519-26-000115:5
2,637 股Class A Common StockSEC:0001809519-26-000115:2
1,686 股Class A Common StockSEC:0001809519-26-000115:4
1,252 股Class A Common StockSEC:0001809519-26-000115:0
20 条申报中的 20 条
About Chan Thomas (TC)
Chan Thomas (TC) is Chief Financial Officer and Chief Accounting Officer at GoodRx Holdings, Inc. The record shows 12 filings in total, and across the 12 sampled filings the most frequent transaction nature is option exercise, with filings dated from 2026-05-15 to 2026-07-16.
